Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin

Journal of Investigative Dermatology

Volumn 121, Issue 5, 2003, Pages 1104-1117

  Westergaard, Majken ^a   Henningsen, Jeanette ^a   Johansen, Claus ^b   Rasmussen, Sofie ^a   Svendsen, Morten Lyhne ^b   Jensen, Uffe Birk ^b   Schrøder, Henrik Daa ^a   Staels, Bart ^c   Iversen, Lars ^b   Bolund, Lars ^b   Kragballe, Knud ^b   Kristiansen, Karsten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIV LILLE   (France)

Author keywords

Immunohistochemistry; I B ; Keratinocytes; NF B p50; NF B p65

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P300; PROTEIN P50; SYNAPTOTAGMIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; PSORIASIS VULGARIS; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION;

EID: 10744228768     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12536.x     Document Type: Article

References (85)

1. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK: Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272:5128-5132, 1997
2. Baeuerle PA: Pro-inflammatory signaling: Last pieces in the NF-κB puzzle? Curr Biol 8:R19-R22, 1998
3. Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP: Deactivarion of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth. J Clin Invest 105:1723-1730, 2000
4. Barnes PJ, Karin M: Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
5. Berth-Jones J, Hutchinson PE: Vitamin D analogues and psoriasis. Br J Dermatol 127:71-78, 1992
6. Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL: Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis. Oncogene 18:7423-7431, 1999
7. Camp HS, Tafuri SR: Regulation of peroxisome proliferator-activatcd receptor γ activity by mitogen-activated protein kinase. J Biol Chem 272:10811-10816, 1997
8. Camp HS, Tafuri SR, Leff T: c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity. Endocrinol 140:392-397, 1999
9. Camp RD, Mallet AI, Woollard PM, Brain SD, Black AK, Greaves MW: The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins 26:431-447, 1983
10. Chinetti G, Griglio S, Antonucci M, et al. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273:25573-25580, 1998
11. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS: Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB. J Biol Chem 275: 32681-32687, 2000
12. Delerive P, De B, Besnard S, et al: Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem 274:32048-32054, 1999
13. Delerive P, Gervois P, Fruchart JC, Staels B: Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 275:36703-36707, 2000
14. Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B: DNA binding-independent induction of IκBα gene transcription by PPARα. Mol Endocrinol 16:1029-1039, 2002
15. Devchand PR, Keller H, Peters JM, Vaquez M, Gonzalez FJ, Wahli W: The PPARα-leukotriene B4 pathway to inflammation control. Nature 384:39-43, 1996
16. Di-Poï N, Tan MS, Michalik L, Wahli W, Desvergne B: Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10:721-733, 2002
17. Ellis CN, Varani J, Fisher GJ, et al: Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation. Arch Dermatol 136:609-616, 2000
18. Fogh K, Herlin T, Kragballe K: Eicosanoids in acute and chronic psoriatic lesions: Leukotriene B4, but not 12-hydroxy-cicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions. J Invest Dermatol 92:837-841, 1989
19. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-δ12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83:803-812, 1995
20. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty-acids, and eicosanoids are ligands for peroxisome proliferator-activated receptor-α and receptor-δ. Proc Natl Acad Sci USA 94:4312-4317, 1997
21. Fuchs E, Raghavan S: Getting under the skin of epidermal morphogenesis. Nat Rev Genet 3:199-209, 2002
22. Ghosh S, Karin M: Missing pieces in the NF-κB puzzle. Cell 109:S81-S96, 2002
23. Hammarstrom S, Hamberg M, Samuelsson B, Duell EA, Stawiski M, Voorhees JJ: Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2α in epidermis of psoriasis. Proc Natl Acad Sci USA 72:5130-5134, 1975
24. Hanley K, Jiang Y, Crumrine D, et al: Activators of the nuclear hormone receptors PPARα and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100:705-712, 1997
25. Hanley K, Jiang Y, He SS, et al: Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARα. J Invest Dermatol 110:368-375, 1998
26. Hanley K, Komuves LG, Bass NM, et al. Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol 113:788-795, 1999
27. Hanley K, Komuves LG, Ng DC, et al: Farnesol stimulates differentiation in epidermal keratinocytes via PPARα. J Biol Chem 275:11484-11491, 2000
28. Hansen JB, Zhang H, Rasmussen TH, Petersen RK, Flindt EN, Kristiansen K: Peroxisome proliferator-activated receptor δ (PPARδ) -mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J Biol Chem 276:3175-3182, 2001
29. He TC, Chan TA, Vogelstein B, Kinzler KW: PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345, 1999
30. van Hogerlinden M, Rozell BL, Ahrlund-Richter L, Toftgard R: Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res 59:3299-3303, 1999
31. Hsi LC, Wilson L, Nixon J, Eling TE: 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor γ via the MAPK signaling pathway. J Biol Chem 276:34545-34552, 2001
32. Hu E, Kim JB, Sarraf P, Spiegelman BM: Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103, 1996
33. Hu Y, Baud V, Delhase M, et al: Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284:316-320, 1999
34. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M: IKKα controls formation of the epidermis independently of NF-κB. Nature 410:710-714, 2001
35. Itin PH, Pittelkow MR, Kumar R: Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinol 135:1793-1798, 1994
36. Jehl P, Bastie C, Gillot I, Luquet S, Grimaldi PA: Peroxisome- proliferator-activated receptor δ mediates the effects of long-chain fatty acids on post-confluent cell proliferation. Biochem J 350 Part 1:93-98, 2000
37. Jiang C, Ting AT, Seed B: PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86, 1998
38. Johansen C, Iversen L, Ryborg A, Kragballe K: 1α,25- dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol 114: 1174-1179, 2000
39. Juge-Aubry CE, Hammar E, Siegrist-Kaiser C, et al: Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor α by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem 274:10505-10510, 1999
40. Kaufman CK, Fuchs E: It's got you covered. NF-κB in the epidermis. J Cell Biol 149:999-1004, 2000
41. Klement JF, Rice NR, Car BD, et al: IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol Cell Biol 16:2341-2349, 1996
42. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819, 1995
43. Kliewer SA, Sundseth SS, Jones SA, et al: Fatty-acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptor-α and receptor-γ. Proc Natl Acad Sci USA 94:4318-4323, 1997
44. Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR: Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 111:429-433, 1998
45. Komuves LG, Hanley K, Lefebvre AM, et al: Stimulation of PPARα promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 115:353-360, 2000a
46. Komuves LG, Hanley K, Man MQ, Elias PM, Williams ML, Feingold KR: Keratinocyte differentiation in hyperproliferative epidermis. Topical application of PPARα activators restores tissue homeostasis. J Invest Dermatol 115:361-367, 2000b
47. Kragballe K, Fallon JD: Increased aggregation and arachidonic acid transformation by psoriatic platelets: Evidence that platelet-derived 12-hydroxy-eicosatetraenoic acid increases keratinocyte DNA synthesis in vitro. Arch Dermatol Res 278:449-453, 1986
48. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W: Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11:779-791, 1997
49. Kussmann-Gerber S, Kratchmarova I, Mandrup S, Kristiansen K: Microaffinity columns for analysis of protein-protein interactions. Anal Biochem 271:102-105, 1999
50. Li M, Indra AK, Warot X, et al: Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis. Nature 407:633-636, 2000a
51. Li M, Pascual G, Glass CK: Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol 20: 4699-4707, 2000b
52. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC, Verma IM: IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 13:1322-1328, 1999
53. Madsen P, Rasmussen HH, Leffers H, et al: Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly upregulated in psoriatic skin. J Invest Dermatol 97:701-712, 1991
54. Makris C, Godfrey VL, Krahn-Senftleben G, et al: Female mice heterozygous for IKKγ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 5:969-979, 2000
55. Mani I, Iversen L, Ziboh VA: Upregulation of nuclear PKC and MAP-kinase during hyperproliferation of guinea pig epidermis: Modulation by 13-(S)-hydroxyoctadecadienoic acid (13-HODE). Cell Signal 10:143-149, 1998
56. Matsuura H, Adachi H, Smart RC, Xu X, Arata J, Jetten AM: Correlation between expression of peroxisome proliferator-activated receptor β and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol 147:85-92, 1999
57. Michalik L, Desvergne B, Tan NS, et al: Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) α and PPAR β mutant mice. J Cell Biol 154:799-814, 2001
58. Pasparakis M, Courtois G, Hafner M, et al: TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417:861-866, 2002
59. Pillai S, Bikle DD: Epidermal vitamin D metabolism, function, and regulation. Adv Lipid Res 24:321-341, 1991
60. Poynter ME, Daynes RA: Peroxisome proliterator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273: 32833-32841, 1998
61. Qin JZ, Bacon P, Chaturvedi V, Nickoloff BJ: Role of NF-κB activity in apoptotic response of keratinocytes mediated by interteron-γ, tumor necrosis factor-α, and tumor-necrosis-factor-related apoptosis-inducing ligand. J Invest Dermatol 117:898-907, 2001
62. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK: The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82, 1998
63. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S: Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 111:1116-1121, 1998
64. Rivier M, Castiel I, Safonova I, Ailhaud G, Michel S: Peroxisome proliferator-activated receptor-α enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 114:681-687, 2000
65. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W: IκB kinases phosphorylate NF-κB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356, 1999
66. Schmidt-Supprian M, Bloch W, Courtois G, Addicks K, Israel A, Rajewsky K, Pasparakis M: NEMO/IKKγ-deficient mice model incontinentia pigmenti. Mol Cell 5:981-992, 2000
67. Schmidt-Ullrich R, Aebischer T, Hulsken J, Birchmeier W, Klemm U, Scheidereit C: Requirement of NF-κB/Rel for the development of hair follicles and other epidermal appendices. Development 128:3843-3853, 2001
68. Seitz CS, Lin Q, Deng H, Khavari PA: Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc Natl Acad Sci USA 95:2307-2312, 1998
69. Seitz CS, Deng H, Hinata K, Lin Q, Khavari PA: Nuclear factor κB subunits induce epithelial cell growth arrest. Cancer Res 60:4085-4092, 2000a
70. Seitz CS, Freiberg RA, Hinata K, Khavari PA: NF-κB determines localization and features of cell death in epidermis. J Clin Invest 105:253-260, 2000b
71. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW, Meier CA: The peroxisome proliferator-activated receptor α is a phosphoprotein: Regulation by insulin. Endocrinol 137:4499-4502, 1996
72. Staels B, Koenig W, Habib A, et al: Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 393:790-793, 1998
73. Stern RS: Psoriasis. Lancet 350:349-353, 1997
74. Straus DS, Pascual G, Li M, et al: 15-deoxy-δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA 97:4844-4849, 2000
75. Su CG, Wen X, Bailey ST, et al: A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104:383-389, 1999
76. Takeda K, Takeuchi O, Tsujimura T, et al: Limb and skin abnormalities in mice lacking IKKα. Science 284:313-316, 1999
77. Tan NS, Michalik L, Noy N, et al: Critical roles of PPAR β/δ in keratinocyce response to inflammation. Genes Dev 15:3263-3277, 2001
78. Terui T, Ozawa M, Tagami H: Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: A neutrophil-associated inflammation-boosting loop. Exp Dermatol 9:1-10, 2000
79. Thuillier P, Brash AR, Kehrer JP, et al: Inhibition of PPAR-mediated keratinocyte differentiation by lipoxygenase inhibitors. Biochem J 366:901-910, 2002
80. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701-705, 1993
81. Westergaard M, Henningsen J, Svendsen ML, et al: Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. J Invest Dermatol 116:702-712, 2001
82. Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARs: From orphan receptors to drug discovery. J Med Chem 43:527-550, 2000
83. Woollard PM: Stereochemical difference between 12-hydroxy-5,8,10,14- eicosatetraenoic acid in platelets and psoriatic lesions. Biochem Biophys Res Commun 136: 169-176, 1986
84. Xu L, Glass CK, Rosenfeld MG: Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 9:140-147, 1999
85. Yu K, Bayona W, Kallen CB, et al: Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270:23975-23983, 1995